FDMT - Cantor analysts call for RFK Jr. replacement following ousting of Marks at FDA
2025-04-01 01:03:31 ET
More on CRISPR Therapeutics, Moderna
- FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)
- CRISPR Therapeutics Set To Reach Previous Heights
- Intel And Crispr: 2 'Bond-Like' Option Trades Yielding 13%+
- How Peter Marks' FDA departure is impacting pharma, biotech stocks
- Biggest stock movers Monday: COOP, HSMT, CYRX, PCVX, MRNA, NNOX and more